Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Sackler

OxyContin maker Purdue Pharma's settlement, by the numbers

OxyContin maker Purdue Pharma's deal to resolve thousands of lawsuits over the toll of opioids is taking effect Friday and the company is being replaced by a new entity

The Independent UK · May 1

OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves

OxyContin maker Purdue Pharma is expected to be ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller

The Independent UK · Apr 28

Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers

A judge is set to explain why he's approving a plan for OxyContin maker Purdue Pharma to settle thousands of lawsuits over the toll of opioids

The Independent UK · Nov 18, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know

OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval

The Independent UK · Nov 15, 2025

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market

Purdue Pharma won court approval to exit bankruptcy, ending six years of litigation over its multibillion-dollar opioid settlement and the Sackler family’s liability releases. Purdue's Chapter 11 plan provides an estimated $7.4 billion to address nationwide opioid harm.

Benzinga · Nov 14, 2025

Judge to approve $7bn settlement with OxyContin maker that requires Sackler family members to pay victims

Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm

The Guardian - US · Nov 14, 2025

Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections

The company that makes OxyContin, members of the Sackler family who own it and many groups that sued over its role in the opioid crisis are asking a judge to approve a settlement plan

The Independent UK · Nov 14, 2025

Read news from The Economist, FT, and more,
with one subscription

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK · Jun 20, 2025

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK · Jun 18, 2025

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK · Jun 16, 2025

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

Al Jazeera · Jun 16, 2025

10 Times the Rich Used Charities to Hide Their Wealth

When you think about charitable giving, you probably picture genuine philanthropy and heartfelt generosity. However, the world of charitable tax avoidance reveals a darker side where some wealthy individuals have exploited the system for personal gain. These schemes don’t just bend the rules—they often break them entirely, costing taxpayers billions…

The Free Financial Advisor · May 30, 2025

Eat the rich films have run their course

The bland satire in "Death of a Unicorn" makes its message unappetizing; there are tastier options

Salon · Apr 4, 2025

Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved

The Independent UK · Jan 23, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

Latin Times · Jan 23, 2025

New York AG Blasts Sackler Family While Announcing $7.4 Billion Purdue Pharma Settlement: 'No Amount of Money Will Ever Fully Repair The Damage They Caused'

New York's AG shared news of The Sackler family and Purdue Pharma settlement, while stating "no amount of money" could reverse the destruction caused.

The Independent UK · Jan 23, 2025

Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller

Top News · Jul 9, 2024

Purdue Pharma Faces Challenges In Opioid Lawsuit Settlement

Purdue Pharma seeks new settlement after Supreme Court rejection in opioid crisis fallout.

The Independent UK · Jul 9, 2024

The threat of litigation looms as Purdue Pharma returns to settlement talks

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US · Jul 1, 2024

US supreme court decisions: the biggest cases this term and their outcomes

The court has wrapped up its term, issuing a string of blockbuster decisions with the conservative supermajority in the driver’s seat

The Conversation · Jun 27, 2024

Supreme Court rejects settlement with OxyContin maker Purdue Pharma over legal protections for the Sackler family that owned the company

The Supreme Court ruled 5-4 against an estimated US$6 billion Purdue Pharma bankruptcy plan on June 27, 2024, that would have shielded the Sackler family – which owned and controlled the company – from legal liability.

International Business Times · Jun 27, 2024

SCOTUS Reverses Purdue Pharma Opioid Settlement, Threatening Billions For Victims

The ruling dealt a blow to Purdue Pharma's bankruptcy reorganization plan, which aimed to allocate billions of dollars to victims of opioid addiction while shielding the Sackler family from future lawsuits.

France 24 · Jun 27, 2024

US Supreme Court rejects $6 billion OxyContin settlement shielding Sackler family

The US Supreme Court on Thursday rejected OxyContin maker Purdue Pharma's $6 billion settlement that would have shielded the Sackler family, who owned the company and earned tens of billions as it flooded the country with the highly addictive drug, from future civil lawsuits over the role they played in…

Top News · Jun 27, 2024

Supreme Court Rejects Opioid Settlement Shielding Sackler Family

Supreme Court rejects opioid settlement involving Sackler family, citing bankruptcy law misalignment and potential unfairness to victims.

The Independent UK · Jun 27, 2024

Supreme Court shreds nationwide $6 billion opioid settlement plan in ruling against Sackler family

The Supreme Court said the Sackler family cannot use a Chapter 11 reorganization plan to protect themselves from civil liability

The Guardian - US · Jun 27, 2024

US supreme court blocks Purdue Pharma’s bankruptcy settlement that would shield Sacklers from lawsuits

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.